Taiho Ventures

What is Taiho Ventures?

Taiho Ventures is the corporate venture capital arm of Taiho Pharmaceutical Company, focusing on early-stage investments in innovative companies across the biotechnology, hardware, medical device, healthcare, and pharmaceutical sectors. Based in Menlo Park, California, Taiho Ventures aims to extend its influence and reach within the life sciences and healthcare industry through strategic investments, with a strong interest in drug discovery, medical devices, diagnostics, and digital health services.

With assets under management amounting to $150 million, Taiho Ventures seeks to support groundbreaking technologies and entrepreneurial ventures that have the potential to significantly improve health outcomes. They offer financial backing ranging from a minimum of $100,000 to a maximum of $5 million, with a preferred 'sweet spot' investment size of about $1.5 million.

The firm typically engages at seed and pre-seed stages, leveraging its industry knowledge and network to propel portfolio companies forward. They are dedicated to contributing to the global biotech venture community by providing both capital and access to insights and partnerships instrumental for developing innovative science that can meet unmet medical needs.

As expressed on their website, Taiho Ventures' mission encapsulates the generation of substantial values through their investments, which are ultimately aimed at supporting the parent company, Taiho Pharmaceutical Co., Ltd., in advancing their pipeline and expanding their scientific horizons.